OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Incidence of Diabetes in Children and Adolescents During the COVID-19 Pandemic
D.M. D'Souza, Jessica Empringham, Petros Pechlivanoglou, et al.
JAMA Network Open (2023) Vol. 6, Iss. 6, pp. e2321281-e2321281
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

The immunology of type 1 diabetes
Kevan C. Herold, Thomas Delong, Ana Luisa Perdigoto, et al.
Nature reviews. Immunology (2024) Vol. 24, Iss. 6, pp. 435-451
Open Access | Times Cited: 41

Immunological and virological triggers of type 1 diabetes: insights and implications
Joana Lemos, Khemraj Hirani, Matthias von Herrath
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 18

Increasing prevalence of thyroid autoimmunity in childhood type 1 diabetes in the pre-COVID but not during the COVID era
Vivien Herczeg, Eszter Muzslay, Diána Czipó, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access | Times Cited: 1

Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people
Kurt Taylor, Sophie V. Eastwood, Venexia Walker, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 12, Iss. 8, pp. 558-568
Open Access | Times Cited: 6

The INNODIA Type 1 Diabetes Natural History Study: a European cohort of newly diagnosed children, adolescents and adults
M. Loredana Marcovecchio, Emile Hendriks, Carl Delfin, et al.
Diabetologia (2024) Vol. 67, Iss. 6, pp. 995-1008
Open Access | Times Cited: 5

Trends in the Incidence of Type 1 Diabetes in European Children and Adolescents from 1994 to 2022: A Systematic Review and Meta-Analysis
Marta Carolina Ruiz-Grao, Ana Díez‐Fernández, Arthur Eumann Mesas, et al.
Pediatric Diabetes (2024) Vol. 2024, pp. 1-13
Open Access | Times Cited: 5

The relationship between SARS-CoV-2 infection and type 1 diabetes mellitus
Cyril Debuysschere, Magloire Pandoua Nekoua, Enagnon Kazali Alidjinou, et al.
Nature Reviews Endocrinology (2024) Vol. 20, Iss. 10, pp. 588-599
Closed Access | Times Cited: 5

Human vascularized macrophage-islet organoids to model immune-mediated pancreatic β cell pyroptosis upon viral infection
Liuliu Yang, Yuling Han, Tuo Zhang, et al.
Cell stem cell (2024) Vol. 31, Iss. 11, pp. 1612-1629.e8
Open Access | Times Cited: 5

Type 1 diabetes incidence during COVID-19 pandemic has not been influenced by COVID-19 vaccination in northern Italy region, Lombardy
Chiara Mameli, Camilla Valsecchi, Danilo Cereda, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0316340-e0316340
Open Access

IFN-α Induces Heterogenous ROS Production in Human β-Cells
Lianna H. Wagner, Olha Melnyk, Abigail Norris Turner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Early-childhood body mass index and its association with the COVID-19 pandemic, containment measures and islet autoimmunity in children with increased risk for type 1 diabetes
Sandra Hummel, Sarah Rosenberger, Thekla von dem Berge, et al.
Diabetologia (2024) Vol. 67, Iss. 4, pp. 670-678
Open Access | Times Cited: 3

Challenging directions in pediatric diabetes - the place of oxidative stress and antioxidants in systemic decline
Vasile Valeriu Lupu, Ingrith Miron, Laura Mihaela Trandafir, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3

Elucidating the Underlying Mechanisms of the Marked Increase in Childhood Type 1 Diabetes During the COVID-19 Pandemic—The Diabetes Pandemic
Clemens Kamrath, Reinhard W. Holl, Joachim Rosenbauer
JAMA Network Open (2023) Vol. 6, Iss. 6, pp. e2321231-e2321231
Open Access | Times Cited: 8

New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Anca Pantea Stoian, Cristina Bică, Teodor Salmen, et al.
Diabetes Therapy (2023) Vol. 15, Iss. 1, pp. 33-60
Open Access | Times Cited: 8

Acute health care use among children during the first 2.5 years of the COVID-19 pandemic in Ontario, Canada: a population-based repeated cross-sectional study
Carina Iskander, Thérèse A. Stukel, Christina Diong, et al.
Canadian Medical Association Journal (2024) Vol. 196, Iss. 1, pp. E1-E13
Open Access | Times Cited: 2

The Roles of Glutathione and Oxidative Stress in Diabetes and COVID-19
Evan Los, George S. Ford, Dawn Tuell, et al.
(2024)
Open Access | Times Cited: 2

Association between COVID-19 and the incidence of type 1 diabetes in Portugal – a registry study
Morten Bjerregaard-Andersen, Jéssica Da Silva, Rui Diogo, et al.
BMC Endocrine Disorders (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Patterns of incidence and characteristics of youth with new-onset diabetes mellitus during the COVID era
Emily L. Montgomery, Kahir Jawad, Kupper A. Wintergerst, et al.
Journal of Pediatric Endocrinology and Diabetes (2024), pp. 1-9
Closed Access | Times Cited: 2

Incidence of Type 1 Diabetes in Children Has Fallen to Pre–COVID-19 Pandemic Levels: A Population-Wide Analysis From Scotland
William Berthon, Stuart J. McGurnaghan, Luke A. K. Blackbourn, et al.
Diabetes Care (2023) Vol. 47, Iss. 3, pp. e26-e28
Open Access | Times Cited: 7

Diabetes following SARS-CoV-2 infection: Incidence, persistence, and implications of COVID-19 vaccination. A cohort study of fifteen million people
Kurt Taylor, Sophie V. Eastwood, Venexia Walker, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 5

Translation of cell therapies to treat autoimmune disorders
Jinal M. Mehta, Shivani C. Hiremath, Chishiba Chilimba, et al.
Advanced Drug Delivery Reviews (2023) Vol. 205, pp. 115161-115161
Closed Access | Times Cited: 5

Cycloartobiloxanthone, a Flavonoid with Antidiabetic, Antibacterial and Anticancer Activities from Artocarpus kemando Miq.
Tati Suhartati, Antin S. Prihatin, Armidla N. Kurniati, et al.
Emerging Science Journal (2024) Vol. 8, Iss. 1, pp. 43-60
Open Access | Times Cited: 1

Post-COVID and diabetes mellitus
Lena Bandelin-Franke, Carmen Scheibenbogen, Thomas Bobbert
Deleted Journal (2024) Vol. 20, Iss. 3, pp. 356-363
Closed Access | Times Cited: 1

Page 1 - Next Page

Scroll to top